The weight loss drug shortage is over — and some patients are 'panicking'
For Maria Rising, managing her health felt like chasing a phantom. The 30-year-old Lansing, Mich. consultant has for years ...
Mathrubhumi English10h
Ramadan and diabetes: A doctor’s guide to safe fasting
What are the key medical considerations for people with diabetes who wish to fast during Ramadan and how can they assess ...
I lost over 8st on fat jabs & it completely transformed my face – trolls say I now look 20 years older but I don’t care
WEIGHT loss jabs have become the latest fad for changing your appearance. It seems as though half of Hollywood is using ...
The Manila Times5h
vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes
Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetes. CATT1 Phase 3 trial expected to ...
All the stars who have used Ozempic to lose weight and those who insist they’ve never touched it despite endless rumours
IT’S hard to imagine a time when the word ‘Ozempic’ wasn’t part of our vocabulary.  For years, celebs have embraced the ...
Clinical Advisor3h
Shifting Perspectives: Providing Weight-Inclusive Health Care in the GLP-1 Era
Amid the soaring use of glucagon-like peptide-1 (GLP-1) drugs for intentional weight loss, a vastly different movement appears to be gaining traction in health care: Many clinicians are pushing for a ...
vTv Therapeutics Inc.: vTv Therapeutics Announces FDA has Lifted Clinical Hold on Cadisegliatin Program for Diabetes
Cadisegliatin has the potential to be the first oral adjunct therapy for type 1 diabetes CATT1 Phase 3 trial expected to resume following submission of protocol amendment shortening the overall durati ...
Refinery29 on MSN1h
This Is How Much I Typically Spend In A Work Week To Manage My Diabetes
Ang, a Las Vegas-based 23-year-old parent program supervisor and social work grad student, began to experience dry skin, but ...
Rolling Out4h
5 serious causes of fatty liver disease
Discover the causes behind fatty liver disease, a condition affecting 25% of adults worldwide, and learn simple lifestyle ...
vTv Therapeutics stock surges on FDA update
Investing.com -- Shares of vTv Therapeutics Inc . (NASDAQ: VTVT) rose 15% after the company announced that the FDA has lifted the clinical hold on its Cadisegliatin program for diabetes. Trading had ...